Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 354.54 billion. The enterprise value is 314.83 billion.
Market Cap | 354.54B |
Enterprise Value | 314.83B |
Important Dates
The last earnings date was Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Boditech Med has 21.79 million shares outstanding. The number of shares has decreased by -0.79% in one year.
Current Share Class | 21.79M |
Shares Outstanding | 21.79M |
Shares Change (YoY) | -0.79% |
Shares Change (QoQ) | -0.26% |
Owned by Insiders (%) | 39.59% |
Owned by Institutions (%) | 1.76% |
Float | 13.04M |
Valuation Ratios
The trailing PE ratio is 12.79 and the forward PE ratio is 10.08.
PE Ratio | 12.79 |
Forward PE | 10.08 |
PS Ratio | 2.46 |
PB Ratio | 1.56 |
P/TBV Ratio | 1.69 |
P/FCF Ratio | 21.10 |
P/OCF Ratio | 12.91 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.54, with an EV/FCF ratio of 18.73.
EV / Earnings | 11.30 |
EV / Sales | 2.18 |
EV / EBITDA | 8.54 |
EV / EBIT | 11.19 |
EV / FCF | 18.73 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.04.
Current Ratio | 4.91 |
Quick Ratio | 3.31 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.22 |
Debt / FCF | 0.48 |
Interest Coverage | 113.00 |
Financial Efficiency
Return on equity (ROE) is 13.08% and return on invested capital (ROIC) is 7.99%.
Return on Equity (ROE) | 13.08% |
Return on Assets (ROA) | 7.22% |
Return on Invested Capital (ROIC) | 7.99% |
Return on Capital Employed (ROCE) | 12.26% |
Revenue Per Employee | 279.93M |
Profits Per Employee | 54.10M |
Employee Count | 515 |
Asset Turnover | 0.59 |
Inventory Turnover | 1.58 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.45% in the last 52 weeks. The beta is 0.25, so Boditech Med's price volatility has been lower than the market average.
Beta (5Y) | 0.25 |
52-Week Price Change | -7.45% |
50-Day Moving Average | 16,179.40 |
200-Day Moving Average | 16,439.80 |
Relative Strength Index (RSI) | 48.80 |
Average Volume (20 Days) | 144,919 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 144.17 billion and earned 27.86 billion in profits. Earnings per share was 1,271.89.
Revenue | 144.17B |
Gross Profit | 85.16B |
Operating Income | 28.31B |
Pretax Income | 33.21B |
Net Income | 27.86B |
EBITDA | 37.05B |
EBIT | 28.31B |
Earnings Per Share (EPS) | 1,271.89 |
Balance Sheet
The company has 60.19 billion in cash and 8.02 billion in debt, giving a net cash position of 52.17 billion or 2,394.14 per share.
Cash & Cash Equivalents | 60.19B |
Total Debt | 8.02B |
Net Cash | 52.17B |
Net Cash Per Share | 2,394.14 |
Equity (Book Value) | 226.77B |
Book Value Per Share | 9,838.19 |
Working Capital | 109.61B |
Cash Flow
In the last 12 months, operating cash flow was 27.47 billion and capital expenditures -10.66 billion, giving a free cash flow of 16.81 billion.
Operating Cash Flow | 27.47B |
Capital Expenditures | -10.66B |
Free Cash Flow | 16.81B |
FCF Per Share | 771.26 |
Margins
Gross margin is 59.07%, with operating and profit margins of 19.64% and 19.33%.
Gross Margin | 59.07% |
Operating Margin | 19.64% |
Pretax Margin | 23.04% |
Profit Margin | 19.33% |
EBITDA Margin | 25.70% |
EBIT Margin | 19.64% |
FCF Margin | 11.66% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 0.92%.
Dividend Per Share | 150.00 |
Dividend Yield | 0.92% |
Dividend Growth (YoY) | -25.00% |
Years of Dividend Growth | 1 |
Payout Ratio | 15.77% |
Buyback Yield | 0.79% |
Shareholder Yield | 1.72% |
Earnings Yield | 7.86% |
FCF Yield | 4.74% |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
Last Split Date | Apr 5, 2017 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 9.17.
Altman Z-Score | 9.17 |
Piotroski F-Score | n/a |